TEL AVIV, Feb 14 Israeli software provider Nice
reported a higher-than-expected rise in quarterly net
profit and forecast continued growth in 2019, boosted by demand
for its cloud and analytics tools.
ZURICH, Feb 1 Novartis's Kymriah cell
therapy won the blessing of health authorities in England for
adult lymphoma patients, the Swiss drugmaker said on Friday,
reversing last year's rejection.
JERUSALEM, Nov 8 Israeli software provider Nice
reported a higher-than expected 18 percent rise in
quarterly net profit, boosted by continued growth in its cloud
and analytics tools.